Methylation Markers of Early-Stage Non-Small Cell Lung Cancer

Background Despite of intense research in early cancer detection, there is a lack of biomarkers for the reliable detection of malignant tumors, including non-small cell lung cancer (NSCLC). DNA methylation changes are common and relatively stable in various types of cancers, and may be used as diagnostic or prognostic biomarkers. Methods We performed DNA methylation profiling of samples from 48 patients with stage I NSCLC and 18 matching cancer-free lung samples using microarrays that cover the promoter regions of more than 14,500 genes. We correlated DNA methylation changes with gene expression levels and performed survival analysis. Results We observed hypermethylation of 496 CpGs in 379 genes and hypomethylation of 373 CpGs in 335 genes in NSCLC. Compared to adenocarcinoma samples, squamous cell carcinoma samples had 263 CpGs in 223 hypermethylated genes and 513 CpGs in 436 hypomethylated genes. 378 of 869 (43.5%) CpG sites discriminating the NSCLC and control samples showed an inverse correlation between CpG site methylation and gene expression levels. As a result of a survival analysis, we found 10 CpGs in 10 genes, in which the methylation level differs in different survival groups. Conclusions We have identified a set of genes with altered methylation in NSCLC and found that a minority of them showed an inverse correlation with gene expression levels. We also found a set of genes that associated with the survival of the patients. These newly-identified marker candidates for the molecular screening of NSCLC will need further analysis in order to determine their clinical utility.

[1]  Jian Ni,et al.  Cell Cycle Regulation by Galectin-12, a New Member of the Galectin Superfamily* , 2001, The Journal of Biological Chemistry.

[2]  A. Sommer,et al.  Aspects of lung cancer gene expression profiling. , 2004, Current opinion in drug discovery & development.

[3]  K. Yoo,et al.  Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Fraga,et al.  Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis , 2010, Melanoma research.

[5]  G. Pfeifer,et al.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. , 2010, Advances in genetics.

[6]  T. Sørlie,et al.  Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression , 2010, Molecular oncology.

[7]  G. Watanabe,et al.  Different histological types of non‐small cell lung cancer have distinct folate and DNA methylation levels , 2009, Cancer science.

[8]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[9]  K. Gunderson,et al.  Genome-wide DNA methylation profiling using Infinium® assay. , 2009, Epigenomics.

[10]  Jonathan R Pollack,et al.  The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. , 2005, Cancer research.

[11]  Daiya Takai,et al.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Zienolddiny,et al.  DNA methylation of the CYP1A1 enhancer is associated with smoking‐induced genetic alterations in human lung , 2012, International journal of cancer.

[13]  Peter A. Jones,et al.  Epigenetic changes in cancer , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  M. Nelson,et al.  Cytosine methylation profiles as a molecular marker in non-small cell lung cancer. , 2006, Cancer research.

[15]  W. Travis,et al.  The new World Health Organization classification of lung tumours , 2001, European Respiratory Journal.

[16]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[17]  Chun Xing Li,et al.  Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.

[18]  M. Esteller.  Epigenetic changes in cancer , 2011, F1000 biology reports.

[19]  Michael Q. Zhang,et al.  Large-scale structure of genomic methylation patterns. , 2005, Genome research.

[20]  A. Bardelli,et al.  Expression and functional regulation of myoglobin in epithelial cancers. , 2009, The American journal of pathology.

[21]  Terence Dwyer,et al.  American Journal of Epidemiology Review Prospects for Epigenetic Epidemiology , 2022 .

[22]  M. Manns,et al.  Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. , 1999, The Biochemical journal.

[23]  S. Uribe-Lewis,et al.  Molecular mechanisms of genomic imprinting and clinical implications for cancer , 2011, Expert Reviews in Molecular Medicine.

[24]  Natalie Jäger,et al.  Genome-wide mapping of DNA methylation: a quantitative technology comparison , 2010, Nature Biotechnology.

[25]  M. Fukushima,et al.  Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. , 2005, The Annals of thoracic surgery.

[26]  Menghong Sun,et al.  Sox17 regulates proliferation and cell cycle during gastric cancer progression. , 2011, Cancer letters.

[27]  N. H. Khattar,et al.  Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2. , 2005, Journal of biomedical science.

[28]  Bo Wang,et al.  Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: A single center analysis , 2011, Cancer biology & therapy.

[29]  S. Mocellin,et al.  The dual role of tumor necrosis factor (TNF) in cancer biology. , 2010, Current Medicinal Chemistry.

[30]  C. Mountain,et al.  The international system for staging lung cancer. , 2000, Seminars in surgical oncology.

[31]  Andres Metspalu,et al.  Gene Expression Profiles of Non-Small Cell Lung Cancer: Survival Prediction and New Biomarkers , 2011, Oncology.

[32]  E. Gabazza,et al.  Polymorphism of UDP-glucuronosyltransferase 1A7 gene: a possible new risk factor for lung cancer. , 2005, European journal of cancer.

[33]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[34]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[35]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[36]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[37]  R. Mackenzie,et al.  The expression of mitochondrial methylenetetrahydrofolate dehydrogenase-cyclohydrolase supports a role in rapid cell growth. , 2004, Biochimica et biophysica acta.

[38]  Rolf-Edgar Silber,et al.  Journal section: , 2004 .

[39]  Jeanne Kowalski,et al.  Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer , 2009, Molecular Cancer Research.